华北制药：第三季度归母净利润3500.66万元，同比增加14.85%

Core Insights - Company reported a revenue of 2.21 billion yuan for Q3 2025, a year-on-year decrease of 5.12% [1] - Net profit attributable to shareholders was 35.01 million yuan, an increase of 14.85% year-on-year [1] - Basic earnings per share stood at 0.02 yuan [1] Financial Performance - For the first three quarters, the company achieved a revenue of 7.485 billion yuan, reflecting a year-on-year decline of 1% [1] - Net profit attributable to shareholders for the first three quarters was 159 million yuan, showing a significant year-on-year increase of 54.69% [1] - Basic earnings per share for the first three quarters was 0.092 yuan [1]